Overjet vs Retrace
Side-by-side comparison of Overjet and Retrace. See how they stack up in pricing, features, and real-world use cases.
Overjet
by Overjet · Boston, MA
Clinical AI: Diagnostic Imaging
Contact Sales
- Quantitative bone level and caries probability scores, not just detection flags
- Integrates with the PMS systems most dental practices already use
- Supports insurance pre-authorization with objective data
- Enterprise pricing model may not fit solo or small group practices
- No intraoral or CBCT support (radiographs only)
- 01 Real-time caries detection overlay during patient exams
- 02 Bone loss measurement for periodontal case acceptance
- 03 Clinical quality assurance across DSO locations
Overjet is the strongest option for practices that want quantitative measurements on radiographs. The bone level percentage and caries probability scores give clinicians and patients specific numbers to discuss, which helps case acceptance. DSOs get consistency across locations. Solo practices should confirm pricing makes sense at their volume.
Retrace
by Retrace · Unknown
Clinical AI: Treatment Planning
Contact Sales
- Addresses the treatment planning and case presentation workflow rather than diagnostic imaging
- May complement diagnostic AI tools like Overjet, Pearl, or VideaHealth
- No confirmed FDA 510(k) clearance. Practices should verify regulatory status before clinical use
- Less publicly documented than established dental AI competitors
- 01 Generating treatment plans with AI assistance
- 02 Presenting treatment options visually to patients
Retrace targets the treatment planning and case presentation side of dental AI, which is a different niche from the diagnostic imaging tools (Overjet, Pearl, VideaHealth) that dominate the dental AI conversation. However, we were unable to confirm FDA 510(k) clearance for Retrace as of February 2026. The product appears in dental AI market listings and directories, but practices should independently verify its regulatory status and clinical validation before incorporating it into clinical workflows. If you are evaluating dental AI tools, start with the FDA-cleared diagnostic platforms and assess Retrace as a potential complement for the treatment planning workflow, after confirming its current regulatory standing.